O'Brien Patrick, Corpe Christopher Peter
Diet and Cardiovascular Health Group, Diabetes and Nutritional Sciences Division, King's College London, London, United Kingdom.
PLoS One. 2016 Dec 16;11(12):e0167785. doi: 10.1371/journal.pone.0167785. eCollection 2016.
The gastrointestinal tract is responsible for the assimilation of nutrients and plays a key role in the regulation of nutrient metabolism and energy balance. The molecular mechanisms by which intestinal sugar transport are regulated are controversial. Based on rodent studies, two models currently exist that involve activation of the sweet-taste receptor, T1R2/3: an indirect model, whereby luminal carbohydrates activate T1R2/3 expressed on enteroendocrine cells, resulting in the release of gut peptides which in turn regulate enterocyte sugar transport capacity; and a direct model, whereby T1R2/3 expressed on the enterocyte regulates enterocyte function.
To study the direct model of intestinal sugar transport using CaCo-2 cells, a well-established in vitro model of the human enterocyte.
Uptake of 10mM 14C D-Glucose and D-Fructose into confluent CaCo-2/TC7 cells was assessed following 3hr preincubation with sugars and artificial sweeteners in the presence and absence of the sweet taste receptor inhibitor, lactisole. Expression of the intestinal sugar transporters and sweet-taste receptors were also determined by RT-PCR.
In response to short term changes in extracellular glucose and glucose/fructose concentrations (2.5mM to 75mM) carrier-mediated sugar uptake mediated by SGLT1 and/or the facilitative hexose transporters (GLUT1,2,3 and 5) was increased. Lactisole and artificial sweeteners had no effect on sugar transport regulated by glucose alone; however, lactisole increased glucose transport in cells exposed to glucose/fructose. RT-PCR revealed Tas1r3 and SGLT3 gene expression in CaCo-2/TC7 cells, but not Tas1r2.
In the short term, enterocyte sugar transport activities respond directly to extracellular glucose levels, but not fructose or artificial sweeteners. We found no evidence of a functional heterodimeric sweet taste receptor, T1R2/3 in CaCo-2 cells. However, when glucose/fructose is administered together there is an inhibitory effect on glucose transport possibly mediated by T1R3.
胃肠道负责营养物质的吸收,并在营养物质代谢和能量平衡的调节中起关键作用。肠道糖转运的调节分子机制存在争议。基于啮齿动物研究,目前存在两种涉及甜味受体T1R2/3激活的模型:一种间接模型,即腔内碳水化合物激活肠内分泌细胞上表达的T1R2/3,导致肠肽释放,进而调节肠上皮细胞糖转运能力;另一种直接模型,即肠上皮细胞上表达的T1R2/3调节肠上皮细胞功能。
使用CaCo-2细胞(一种成熟的人肠上皮细胞体外模型)研究肠道糖转运的直接模型。
在存在和不存在甜味受体抑制剂乳糖酸的情况下,用糖和人工甜味剂预孵育3小时后,评估10mM 14C D-葡萄糖和D-果糖进入汇合的CaCo-2/TC7细胞的摄取情况。还通过RT-PCR测定肠道糖转运体和甜味受体的表达。
响应细胞外葡萄糖和葡萄糖/果糖浓度的短期变化(2.5mM至75mM),由SGLT1和/或易化己糖转运体(GLUT1、2、3和5)介导的载体介导的糖摄取增加。乳糖酸和人工甜味剂对仅由葡萄糖调节的糖转运没有影响;然而,乳糖酸增加了暴露于葡萄糖/果糖的细胞中的葡萄糖转运。RT-PCR显示CaCo-2/TC7细胞中有Tas1r3和SGLT3基因表达,但没有Tas1r2基因表达。
短期内肠上皮细胞糖转运活性直接响应细胞外葡萄糖水平,而非果糖或人工甜味剂。我们在CaCo-2细胞中未发现功能性异二聚体甜味受体T1R2/3的证据。然而,当一起给予葡萄糖/果糖时,可能由T1R3介导对葡萄糖转运有抑制作用。